Regulation on Methadone Use in the ED

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

2 posts / 0 new
Log in or register to post comments
Last post
Thu, 02/17/2022 - 10:21
#1
mark heelon
mark heelon's picture
Offline
Last seen: 1 week 3 days ago
Joined: 09/05/2014 - 08:51
Regulation on Methadone Use in the ED

Our clinical, regulatory, and legal teams are wrestling with a question that has arisen from some of the complications of COVID. Like many emergency departments, we are holding patients with complex psychiatric needs for placement at other facilities, sometimes for a week or more. Some of these patients also have opioid use disorder and are maintained on methadone. Of note, these patients are NOT admitted to our hospital and are still under the care of our ED providers.

According to the Code of Federal Regulation Title 21 § 1306.07, non-admitted patients are allowed to be managed for a maximum of 3 days on methadone by a provider in this setting. Of course, if the patient is admitted for another reason, we can maintain treatment but that doesn't seem to apply here.

Is anyone else experiencing this situation and are you interpreting this differently? Any strategies you have put in place?

Tags: 

Top